IPP Bureau
Glenmark sets GHG emission targets for FY2035
By IPP Bureau - June 01, 2023
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
HMD supplied 1.75 billion syringes of the total 13.3 billion COVID 19 vaccines administered globally
By IPP Bureau - June 01, 2023
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Synexa Joins CEPI in advancing global epidemic preparedness and response
By IPP Bureau - May 31, 2023
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData
By IPP Bureau - May 31, 2023
The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab
Concept Medical gets 4th IDE approval from USFDA
By IPP Bureau - May 31, 2023
For the treatment of Superficial Femoral Artery
PharmaLytica returns to Hyderabad
By IPP Bureau - May 31, 2023
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
Capnopharm receives CE certification for its new CapnoPen technology
By IPP Bureau - May 31, 2023
Capnopharm’s new CapnoPen is the first PIPAC nebulizer to obtain CE marking under the new MDR regulation 2017/745
Ind-Swift Laboratories reports FY23 PAT at Rs. 42.47 Cr
By IPP Bureau - May 30, 2023
The company reported lifetime high EBIDTA of Rs. 250 crores
Hikal posts FY23 PAT at Rs. 36 Cr
By IPP Bureau - May 30, 2023
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
Jubilant Pharmova posts Q4FY23 consolidated loss at Rs. 97.84 Cr
By IPP Bureau - May 30, 2023
The company has reported total income of Rs. 1682.45 crores during the period ended March 31, 2023
NATCO records FY23 PAT at Rs. 715.3 Cr
By IPP Bureau - May 30, 2023
The increase in revenue and profits for the year was driven by business growth in the US market and growth in our subsidiaries in Canada & Brazil.
SÜDPACK Medica and Liveo Research join forces at Connect in Pharma in Geneva
By IPP Bureau - May 29, 2023
The PP-based top and bottom webs are manufactured in a unique coextrusion process
AiMeD applauds Govt. for launching 3 major Medical Device Policy & Scheme
By IPP Bureau - May 29, 2023
Medical Device Policy is a progressive step in propelling the country towards Atmanirbharta in the heavily import dependent Medical Device Sector
Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22
By IPP Bureau - May 29, 2023
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239